ATE358488T1 - Behandlung von dyskinesie mit 2,3-benzodiazepinen - Google Patents
Behandlung von dyskinesie mit 2,3-benzodiazepinenInfo
- Publication number
- ATE358488T1 ATE358488T1 AT03795090T AT03795090T ATE358488T1 AT E358488 T1 ATE358488 T1 AT E358488T1 AT 03795090 T AT03795090 T AT 03795090T AT 03795090 T AT03795090 T AT 03795090T AT E358488 T1 ATE358488 T1 AT E358488T1
- Authority
- AT
- Austria
- Prior art keywords
- dyskinesia
- benzodiazepines
- treatment
- pakinsonism
- nerisopam
- Prior art date
Links
- 208000012661 Dyskinesia Diseases 0.000 title abstract 3
- 229940049706 benzodiazepine Drugs 0.000 title 1
- RPBDCDQMCRHNLM-UHFFFAOYSA-N C1=NNC=C2C=CC=CC2=C1 Chemical class C1=NNC=C2C=CC=CC2=C1 RPBDCDQMCRHNLM-UHFFFAOYSA-N 0.000 abstract 1
- RUJBDQSFYCKFAA-UHFFFAOYSA-N Tofisopam Chemical compound N=1N=C(C)C(CC)C2=CC(OC)=C(OC)C=C2C=1C1=CC=C(OC)C(OC)=C1 RUJBDQSFYCKFAA-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- VQYLGVVODFDFNK-UHFFFAOYSA-N girisopam Chemical compound C1=2C=C(OC)C(OC)=CC=2CC(C)=NN=C1C1=CC=CC(Cl)=C1 VQYLGVVODFDFNK-UHFFFAOYSA-N 0.000 abstract 1
- 229950002157 girisopam Drugs 0.000 abstract 1
- WWQDEXGFYVSTCX-UHFFFAOYSA-N nerisopam Chemical compound C1=2C=C(OC)C(OC)=CC=2CC(C)=NN=C1C1=CC=C(N)C=C1 WWQDEXGFYVSTCX-UHFFFAOYSA-N 0.000 abstract 1
- 229950001811 nerisopam Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229960002501 tofisopam Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0221248A GB0221248D0 (en) | 2002-09-13 | 2002-09-13 | Treatment of basal ganglia-related movement disorders |
| GB0304227A GB0304227D0 (en) | 2003-02-25 | 2003-02-25 | Treatment of basal ganglia-related movement disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE358488T1 true ATE358488T1 (de) | 2007-04-15 |
Family
ID=31995700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03795090T ATE358488T1 (de) | 2002-09-13 | 2003-09-11 | Behandlung von dyskinesie mit 2,3-benzodiazepinen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20050261282A1 (de) |
| EP (1) | EP1545546B1 (de) |
| JP (1) | JP4630665B2 (de) |
| CN (1) | CN1681512B (de) |
| AT (1) | ATE358488T1 (de) |
| AU (1) | AU2003263357B2 (de) |
| CA (1) | CA2498735C (de) |
| CY (1) | CY1106689T1 (de) |
| DE (1) | DE60313005T2 (de) |
| DK (1) | DK1545546T3 (de) |
| ES (1) | ES2285245T3 (de) |
| PT (1) | PT1545546E (de) |
| WO (1) | WO2004024163A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9924941D0 (en) * | 1999-10-22 | 1999-12-22 | Univ Manchester | Treatment of dyskinesia |
| CN102836162A (zh) * | 2012-04-10 | 2012-12-26 | 珠海亿邦制药股份有限公司 | 一种以托非索泮为活性成分的口服固体制剂及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU179018B (en) * | 1978-10-19 | 1982-08-28 | Gyogyszerkutato Intezet | Process for producing new 5h-2,3-benzodiazepine derivatives |
| US4452808A (en) * | 1982-12-07 | 1984-06-05 | Smithkline Beckman Corporation | 4-Aminoalkyl-2(3H)-indolones |
| US4582916A (en) * | 1983-09-26 | 1986-04-15 | Mcneilab, Inc. | Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol |
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| GB8712073D0 (en) * | 1987-05-21 | 1987-06-24 | Smith Kline French Lab | Medicament |
| DE19604920A1 (de) * | 1996-02-01 | 1997-08-07 | Schering Ag | Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel |
| HUP9701284A3 (en) * | 1997-07-24 | 2005-11-28 | Egyt Gyogyszervegyeszeti Gyar | Use of 2,3-benzodiazepine derivatives for producing pharmaceutical compositions for treating and prophylacting illnesses and conditions connected with the endogene opioide system |
| IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
| WO2000061138A1 (en) * | 1999-04-08 | 2000-10-19 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
| US6420369B1 (en) * | 1999-05-24 | 2002-07-16 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in treating dementia |
| FR2824065A1 (fr) * | 2001-04-26 | 2002-10-31 | Neuro3D | Composes inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations |
| US6649607B2 (en) * | 2001-05-18 | 2003-11-18 | Vela Pharmaceuticals, Inc. | Compositions and methods for treating or preventing convulsions or seizures |
| RU2195284C1 (ru) * | 2001-07-23 | 2002-12-27 | Сибирский государственный медицинский университет | Способ лечения гипертонически-гиперкинетической формы дискинезии желчевыводящих путей у лиц молодого возраста |
| US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
-
2003
- 2003-09-11 DE DE60313005T patent/DE60313005T2/de not_active Expired - Lifetime
- 2003-09-11 DK DK03795090T patent/DK1545546T3/da active
- 2003-09-11 JP JP2004535674A patent/JP4630665B2/ja not_active Expired - Fee Related
- 2003-09-11 WO PCT/GB2003/003951 patent/WO2004024163A1/en not_active Ceased
- 2003-09-11 PT PT03795090T patent/PT1545546E/pt unknown
- 2003-09-11 CN CN038217309A patent/CN1681512B/zh not_active Expired - Fee Related
- 2003-09-11 US US10/527,271 patent/US20050261282A1/en not_active Abandoned
- 2003-09-11 ES ES03795090T patent/ES2285245T3/es not_active Expired - Lifetime
- 2003-09-11 AU AU2003263357A patent/AU2003263357B2/en not_active Ceased
- 2003-09-11 AT AT03795090T patent/ATE358488T1/de active
- 2003-09-11 EP EP03795090A patent/EP1545546B1/de not_active Expired - Lifetime
- 2003-09-11 CA CA2498735A patent/CA2498735C/en not_active Expired - Fee Related
-
2007
- 2007-07-02 CY CY20071100867T patent/CY1106689T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1106689T1 (el) | 2012-05-23 |
| EP1545546A1 (de) | 2005-06-29 |
| CA2498735C (en) | 2011-08-02 |
| JP2006502174A (ja) | 2006-01-19 |
| CN1681512B (zh) | 2011-11-09 |
| WO2004024163A1 (en) | 2004-03-25 |
| US20050261282A1 (en) | 2005-11-24 |
| DK1545546T3 (da) | 2007-08-06 |
| DE60313005D1 (de) | 2007-05-16 |
| CN1681512A (zh) | 2005-10-12 |
| JP4630665B2 (ja) | 2011-02-09 |
| CA2498735A1 (en) | 2004-03-25 |
| PT1545546E (pt) | 2007-07-02 |
| AU2003263357B2 (en) | 2009-02-26 |
| AU2003263357A1 (en) | 2004-04-30 |
| DE60313005T2 (de) | 2007-12-20 |
| EP1545546B1 (de) | 2007-04-04 |
| ES2285245T3 (es) | 2007-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200300717A1 (ru) | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов | |
| BRPI0413449A (pt) | compostos de quinoxalina | |
| ATE401314T1 (de) | Benzodiazepin-derivate als gamma-secretase inhibitoren | |
| MXPA05011643A (es) | 5,7-diaminopirazolo[4,3-d]pirimidinas en el tratamiento de hipertension. | |
| BRPI0411617A (pt) | derivados de pirimidina como ligantes de receptores de canabinóides | |
| GB0223038D0 (en) | Therapeutic compounds | |
| PT1140944E (pt) | Derivados de epotilona e sua utilizacao como agentes antitumorais | |
| MY135477A (en) | 2-(2,6-dichlorophenyl)-diarylimidazoles | |
| CY1106476T1 (el) | Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες | |
| IS8485A (is) | Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki | |
| NZ544244A (en) | Dual NK1/NK3 antagonists for treating schizophrenia | |
| ATE357438T1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| AP2001002188A0 (en) | 5HT1 antagonists for antidepressant therapy. | |
| ATE244712T1 (de) | Piperazino-derivative als neurokininantagonisten | |
| DE60127131D1 (de) | Tricyclische imidazopyridine | |
| DK1438034T3 (da) | Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens | |
| DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
| ATE358488T1 (de) | Behandlung von dyskinesie mit 2,3-benzodiazepinen | |
| BRPI0415355A (pt) | triarilimidazóis | |
| ECSP056057A (es) | Compuestos de benzo[1,2,5]tiadiazole | |
| MXPA06000700A (es) | Compuestos de sulfonildihidroimidazopiridinona como ligandos de 5-hidroxitriptamina-6. | |
| UY26498A1 (es) | Pirroles sustituidos | |
| PT1212119E (pt) | Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas | |
| EA200600115A1 (ru) | Производные 2-аминобензойной кислоты | |
| ATE423780T1 (de) | Makrozyclen zur behandlung von krebserkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1545546 Country of ref document: EP |